Tag:
Paratek Pharmaceuticals
Latest Headlines
Latest Headlines
Paratek forges $485M pact with Novartis on blockbuster antibiotic
Boston-based Paratek Pharmaceuticals scored a worldwide licensing deal with Novartis for its late-stage antibiotic, PTK 0796, which some analysts peg as a likely blockbuster. Paratek didn't disclose
Paratek funds Phase III launch with $40M in VC
Paratek Pharmaceuticals has closed the second tranche on its $40 million round of venture funding. The money allows the Boston-based developer to launch a Phase III trial of the experimental
